SCHEMBL7947472

SCHEMBL7947472

NC(C(=O)c1ccccc1)c1ccccc1N1CCN(c2ccncc2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.43
PLA2G1B P04054 1/20 0.43
ATG4B Q9Y4P1 1/20 0.43
HRH3 Q9Y5N1 1/20 0.42
CYP2C9 P11712 2/20 0.41
F2 P00734 1/20 0.41
F10 P00742 1/20 0.41
PRSS1 P07477 1/20 0.41
CYP2C19 P33261 1/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
MAPT P10636 2/20 0.40
KDM4E B2RXH2 1/20 0.40
GAA P10253 1/20 0.40
ITGB3 P05106 1/20 0.40
ITGA2B P08514 1/20 0.40
USP2 O75604 2/20 0.39
ALDH1A1 P00352 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7947476 0.83 F2 (0.46) SMN1; SMN2HRH3CYP2C9F2F10
SCHEMBL7956807 0.74 CA12 (0.46) SMN1; SMN2CYP2C9CYP2C19CA12CA1
SCHEMBL8631456 0.73 ALDH1A1 (0.56) SMN1; SMN2PLA2G1BATG4BCYP2C9CYP2C19
SCHEMBL7961639 0.72 SMN1; SMN2 (0.70) SMN1; SMN2HRH3CYP2C9CYP2C19MAPT
SCHEMBL10684394 0.72 NPC1 (0.62) SMN1; SMN2CA12CA1CA2CA9
SCHEMBL7947481 0.70 HRH3 (0.47) SMN1; SMN2PLA2G1BATG4BHRH3CYP2C9
SCHEMBL7947608 0.69 MEN1 (0.42) F2F10PRSS1MAPTKDM4E
SCHEMBL7947475 0.69 KMT2A (0.52) SMN1; SMN2PLA2G1BATG4BALDH1A1HPGD
SCHEMBL8632345 0.69 GAA (0.42) SMN1; SMN2HRH3CYP2C9F2F10
SCHEMBL7958298 0.69 MEN1 (0.41) SMN1; SMN2CYP2C9CYP2C19CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6313127-B1 FOR THERAPY OF HYPERCHOLESTEROLEMIA OR ATHEROSCLEROSIS ZENECA LIMITED (GB) 2001-11-06 US disclosed
EP-0880501-A1 HETEROCYCLIC COMPOUNDS USEFUL AS PHARMACEUTICAL AGENTS ZENECA LIMITED (GB) 1998-12-02 EP disclosed
WO-1997028128-A1 HETEROCYCLIC COMPOUNDS USEFUL AS PHARMACEUTICAL AGENTS ZENECA LIMITED (GB) 1997-08-07 WO disclosed